Gilead Sciences Total Non-Operating Income/Expense 2010-2024 | GILD

Gilead Sciences total non-operating income/expense for the twelve months ending June 30, 2024 was $-1.019B, a 9.26% decline year-over-year.

  • Gilead Sciences annual total non-operating income/expense for 2023 was $-0.746B, a 50.79% decline from 2022.
  • Gilead Sciences annual total non-operating income/expense for 2022 was $-1.516B, a 7.56% decline from 2021.
  • Gilead Sciences annual total non-operating income/expense for 2021 was $-1.64B, a 31.72% decline from 2020.

Gilead Sciences Total Non-Operating Income/Expense 2010-2024 | GILD

  • Gilead Sciences annual total non-operating income/expense for 2023 was $-0.746B, a 50.79% decline from 2022.
  • Gilead Sciences annual total non-operating income/expense for 2022 was $-1.516B, a 7.56% decline from 2021.
  • Gilead Sciences annual total non-operating income/expense for 2021 was $-1.64B, a 31.72% decline from 2020.